Alx Oncology Holdings revenue was $0.00 for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ALXO annual revenue was $0.0, with N/A growth year-over-year.
ALXO past revenue growth
How has ALXO's revenue growth performed historically?
On Invalid Date, Alx Oncology Holdings (NASDAQ: ALXO) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Alx Oncology Holdings's revenue was $0.00.
What was Alx Oncology Holdings's revenue in 2023?
Alx Oncology Holdings's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
How much does Alx Oncology Holdings make in a day?
Based on Alx Oncology Holdings annual revenue for the past five years, ALXO makes an average of $3,275.62 per day.
What was Alx Oncology Holdings's annual revenue growth in the past year?
As of Q4 2024, Alx Oncology Holdings's revenue has grown null year over year. Alx Oncology Holdings's revenue in the past year totaled $0.00.
How much does Alx Oncology Holdings make in a year?
Alx Oncology Holdings's revenue by year for the past five years is:
Alx Oncology Holdings's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
Alx Oncology Holdings's annual revenue for Dec 31, 2022 was $0.00, a N/A decrease from 2021.
Alx Oncology Holdings's annual revenue for 2021 was $0.00, a 100% decrease from 2020.
Alx Oncology Holdings's annual revenue for 2020 was $1.18 million, a 75.35% decrease from 2019.
Alx Oncology Holdings's annual revenue for 2019 was $4.80 million, a 132.03% increase from 2018.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.